Outlook Therapeutics Inc (OTLK)

[H2R]

Institutional Trading

BlackRock Inc. raised its stake in shares of Outlook Therapeutics by 14.2% during the second quarter. BlackRock Inc. now owns 9,215,800 shares of the company's stock valued at $16,035,000 after acquiring an additional 1,148,372 shares during the last quarter.

Vanguard Group Inc. raised its stake in shares of Outlook Therapeutics by 4.4% during the fourth quarter. Vanguard Group Inc. now owns 6,560,400 shares of the company's stock valued at $2,585,000 after acquiring an additional 277,326 shares during the last quarter.

State Street Corp raised its stake in shares of Outlook Therapeutics by 36.2% during the second quarter. State Street Corp now owns 2,751,977 shares of the company's stock valued at $4,788,000 after acquiring an additional 731,925 shares during the last quarter.

Finally, Geode Capital Management LLC raised its stake in shares of Outlook Therapeutics by 7.2% during the second quarter. Geode Capital Management LLC now owns 2,720,795 shares of the company's stock valued at $4,734,000 after acquiring an additional 183,120 shares during the last quarter. 11.20% of the stock is currently owned by hedge funds and other institutional investors.

https://www.marketbeat.com/instant-alerts/nasdaq-otlk-consensus-analyst-rating-2024-04-13/